Related Experiment Video
Updated: Jul 2, 2026

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Variable Aβ tracer uptake in hyperostosis frontalis interna: implications for brain Aβ PET/CT interpretation
Joseph M Ryan1,2, Hina J Shah1,2, Michael P McCormick3
1Department of Nuclear Medicine Mass General Brigham Boston Massachusetts USA.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|July 1, 2026
Summary
Hyperostosis frontalis interna (HFI) can affect amyloid-beta (Aβ) PET scans. Careful review is needed to avoid misinterpreting tracer uptake in HFI patients, especially older women.
Area of Science:
- Neurology
- Radiology
- Nuclear Medicine
Background:
- Hyperostosis frontalis interna (HFI) is a common incidental finding on head CT scans.
- HFI involves thickening of the inner table of the frontal bone.
- Its impact on amyloid-beta (Aβ) positron emission tomography (PET) imaging is not well understood.
Purpose of the Study:
- To report two cases of HFI identified during amyloid-beta PET/CT imaging.
- To describe distinct patterns of tracer uptake in the calvarium affected by HFI.
- To highlight potential misinterpretations in quantitative PET analyses due to HFI.
Main Methods:
- Two patients with HFI underwent 18F-florbetaben PET/CT imaging.
- Scans were assessed for amyloid-beta plaque burden using Centiloid values.
- Tracer uptake within the HFI region of the calvarium was specifically examined.
Main Results:
- Patient 1 showed marked 18F-florbetaben uptake within the HFI region, with a Centiloid of 59.
- Patient 2 exhibited HFI but no 18F-florbetaben uptake in the affected calvarium, with a Centiloid of 82.
- Distinct patterns of tracer retention were observed in the HFI areas.
Conclusions:
- Off-target tracer retention in HFI can lead to visual and quantitative misinterpretations in Aβ PET scans.
- This is particularly relevant for older women with HFI.
- Careful visual inspection and adjusted quantification masks are crucial for accurate PET measurements in HFI patients.